The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Complementary Roles of Farnesoid X Receptor, Pregnane X Receptor, and Constitutive Androstane Receptor in Protection against Bile Acid Toxicity
Open accessAbstract
The nuclear receptors, farnesoid X receptor (FXR) and pregnane X receptor (PXR), are important in maintaining bile acid homeostasis. Deletion of both FXR and PXR in vivo by cross-breeding B6;129-Fxrtm1Gonz (FXR-null) and B6;129-Pxrtm1Glaxo-Wellcome (PXR-null) mice revealed a more severe disruption of bile acid, cholesterol, and lipid homeostasis in B6;129-Fxrtm1Gonz Pxrtm1Glaxo-Wellcome (FXR-PXR double null or FPXR-null) mice fed a 1% cholic acid (CA) diet. Hepatic expression of the constitutive androstane receptor (CAR) and its target genes was induced in FXR- and FPXR-null mice fed the CA diet. To test whether up-regulation of CAR represents a means of protection against bile acid toxicity to compensate for the loss of FXR and PXR, animals were pretreated with CAR activators, phenobarbital or 1,4-bis[2-(3,5-dichlorpyridyloxy)]benzene (TCPOBOP), followed by the CA diet. A role for CAR in protection against bile acid toxicity was confirmed by a marked reduction of serum bile acid and bilirubin concentrations, with an elevation of the expression of the hepatic genes involved in bile acid and/or bilirubin metabolism and excretion (CYP2B, CYP3A, MRP2, MRP3, UGT1A, and glutathione S-transferase alpha), following pretreatment with phenobarbital or TCPOBOP. In summary, the current study demonstrates a critical and combined role of FXR and PXR in maintaining not only bile acid but also cholesterol and lipid homeostasis in vivo. Furthermore, FXR, PXR, and CAR protect against hepatic bile acid toxicity in a complementary manner, suggesting that they serve as redundant but distinct layers of defense to prevent overt hepatic damage by bile acids during cholestasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Elevated BAs can activate the FXR, pregnane X receptor (PXR), and CAR.54,55”
From Constitutive Androstane Receptor Regulates Bile Acid Homeostasis and Metabolism During Liver Regeneration (2026) · cites this paper as [55]
In the citing paper
“Intrahepatic cholestasis can also activate the constitutive androstane receptor (CAR, NR1I3) (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“We and others have previously demonstrated that elevated bile acids, as observed in mice lacking circadian homeostasis, activates CAR (Guo et al., 2003; Huang et al., 2005; Ma et al., 2009; Zhang et al., 2004)”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
In the citing paper
“which is well known as a potent tumor promoter that drives non-genotoxic hepatocarcinogenesis (Guo et al., 2003; Huang et al., 2005; Yamamoto et al., 2004; Zhang et al., 2004).”
From Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis (2016) · cites this paper as Guo et al., 2003
Citations
Cites
Identification of a nuclear receptor for bile acids
Makishima, M., Okamoto, A. Y., Repa, J. J., Tu, H., Learned, R. M., Luk, A., Hull, M. V., Lustig, K. D., Mangelsdorf, D. J., & Shan, B. (1999) · Science · doi:10.1126/science.284.5418.1362 · Cited by 2,714
Bile Acids: Natural Ligands for an Orphan Nuclear Receptor
Parks, D. J., Blanchard, S. G., Bledsoe, R. K., Chandra, G., Consler, T. G., Kliewer, S. A., Stimmel, J. B., Willson, T. M., Zavacki, A. M., Moore, D. D., et al. (1999) · Science · doi:10.1126/science.284.5418.1365 · Cited by 2,274
Self-citationA regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis
Goodwin, B., Jones, S. A., Price, R. R., Watson, M. A., McKee, D. D., Moore, L. B., Galardi, C., Wilson, J. G., Lewis, M. C., Roth, M. E., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00051-4 · Cited by 1,940
Self-citationTargeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid Homeostasis
Sinal, C. J., Tohkin, M., Miyata, M., Ward, J. M., Lambert, G., & Gonzalez, F. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00062-3 · Cited by 1,819
Self-citationEndogenous Bile Acids Are Ligands for the Nuclear Receptor FXR/BAR
Wang, H., Chen, J., Hollister, K., Sowers, L. C., & Forman, B. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80348-2 · Cited by 1,636
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Staudinger, J. L., Goodwin, B., Jones, S. A., Hawkins-Brown, D., MacKenzie, K. I., LaTour, A., Liu, Y., Klaassen, C. D., Brown, K. K., Reinhard, J., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051551698 · Cited by 1,379
Self-citationIdentification of a nuclear receptor that is activated by farnesol metabolites
Forman, B. M., Goode, E., Chen, J., Oro, A. E., Bradley, D. J., Perlmann, T., Noonan, D. J., Burka, L. T., McMorris, T., Lamph, W. W., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90530-8 · Cited by 1,210
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids
Xie, W., Radominska-Pandya, A., Shi, Y., Simon, C. M., Nelson, M. C., Ong, E. S., Waxman, D. J., & Evans, R. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051014398 · Cited by 757
Maglich, J. M., Stoltz, C. M., Goodwin, B., Hawkins-Brown, D., Moore, J. T., & Kliewer, S. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.638 · Cited by 654
Self-citation
Research works printed but not linked: 2
- Hofmann, 1995, Ital. J. Gastroenterol., 27, 106
- Seol, 1995, Mol. Endocrinol., 9, 72
Cited by
Items 101–200 of 311
The interrelationship between bile acid and vitamin A homeostasis
Saeed, A., Hoekstra, M., Hoeke, M. O., Heegsma, J., & Faber, K. N. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.01.007 · Cited by 96
Soroka, C. J., Mennone, A., Hagey, L. R., Ballatori, N., & Boyer, J. L. (2009) · Hepatology · doi:10.1002/hep.23265 · Cited by 80
Matsusue, K., Gavrilova, O., Lambert, G. C., Brewer, H. B., Ward, J. M., Inoue, Y., LeRoith, D., & Gonzalez, F. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0213 · Cited by 83
Self-citationBile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 90
Phenobarbital Confers its Diverse Effects by Activating the Orphan Nuclear Receptor Car
Kodama, S., & Negishi, M. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569851 · Cited by 79
“While CAR does not regulate the expression of CYP7A, the receptor appears to play a role in bile acid elimination by inducing enzymes and transporters (Guo et al., 2003; Zhang et al., 2004).”
BackgroundSelf-citationLyons, M. A., & Wittenburg, H. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.10.024 · Cited by 80
Cheng, X., & Klaassen, C. D. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010520 · Cited by 76
“Breeding pairs of PXR-null mice in the C57BL/6 background were kindly provided by Dr. Frank J. Gonzalez (Guo et al., 2003), which were originally engineered by inserting neomycin phosphotransferase gene into exon 1 region of the PXR gene (Staudinger et al., 2001b).”
Eveillard, A., Mselli-Lakhal, L., Mogha, A., Lasserre, F., Polizzi, A., Pascussi, J., Guillou, H., Martin, P. G. P., & Pineau, T. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.023 · Cited by 94
“receptors protect the body from the deleterious accumulation of bilirubin [61,62] and bile acids [63] through hepatic induction of several enzyme genes.”
BackgroundThe Role of Canalicular ABC Transporters in Cholestasis
Cuperus, F. J. C., Claudel, T., Gautherot, J., Halilbasic, E., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056358 · Cited by 81
Beilke, L. D., Aleksunes, L. M., Holland, R. D., Besselsen, D. G., Beger, R. D., Klaassen, C. D., & Cherrington, N. J. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023317 · Cited by 73
“These data are consistent with previous reports on the importance of CAR on conjugation enzymes during hepatoprotection (Guo et al., 2003; Huang et al., 2003; Wagner et al., 2005).”
ResultRegulation of hepatic ABCC transporters by xenobiotics and in disease states
Gu, X., & Manautou, J. E. (2010) · Drug Metabolism Reviews · doi:10.3109/03602531003654915 · Cited by 74
“A 1% cholic acid diet slightly induces Mrp2 expression in Fxr-knockout mice (F−/P+, F−/P−) (Guo et al., 2003).”
BackgroundInfluentialNuclear Receptor Ligands: Rational and Effective Therapy for Chronic Cholestatic Liver Disease?
Boyer, J. L. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.06.053 · Cited by 74
Chen, P., Zeng, H., Wang, Y., Fan, X., Xu, C., Deng, R., Zhou, X., Bi, H., & Huang, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.113.056549 · Cited by 76
“Besides Nrf2, three nuclear receptors (FXR, PXR, and CAR) also play important roles in protecting against bile acid toxicity (Guo et al., 2003; Zhang et al., 2004).”
BackgroundCiaula, A. D., Bonfrate, L., Baj, J., Khalil, M., Garruti, G., Stellaard, F., Wang, H. H., Wang, D. Q. ‐., & Portincasa, P. (2022) · Nutrients · doi:10.3390/nu14234950 · Cited by 78
Burrin, D. G., Ng, K., Stoll, B., & de Pipaón, M. S. (2014) · Advances in Nutrition · doi:10.3945/an.113.004796 · Cited by 70
A Double Transgenic Mouse Model Expressing Human Pregnane X Receptor and Cytochrome P450 3A4
Ma, X., Cheung, C., Krausz, K. W., Shah, Y. M., Wang, T., Idle, J. R., & Gonzalez, F. J. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.022723 · Cited by 69
“…Pxr wild-type (WT) and null alleles: forward 5 -CTG GTC ATC ACT GTT GCT GTA CCA-3 reverse1 5 -GCA GCA TAG GAC AAG TTA TTC TAG AG-3 , and reverse2 5 -CTA AAG CGC ATG CTC CAG ACT GC-3 , amplifying a PCR product of 348 bp for the wild-type allele and 265 bp for the Pxr-null allele (Guo et al., 2003).”
BackgroundSelf-citationBaldwin, W. S., & Roling, J. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn206 · Cited by 73
“…is also important in the regulation of bile acid homeostasis and energy metabolism, thus exposure to several low dose CAR activators may affect metabolic diseases, alter bile acid homeostasis, and increase liver disease (Ding et al., 2006; Guo et al., 2003; Wagner et al., 2005; Zhang et al., 2004).”
Primary sclerosing cholangitis
Karlsen, T. H., Schrumpf, E., & Boberg, K. M. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.07.005 · Cited by 77
Regulation of Transporters by Nuclear Hormone Receptors: Implications during Inflammation
Teng, S., & Piquette‐Miller, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700102q · Cited by 81
Coordinate Transcriptional Regulation of Transport and Metabolism
Eloranta, J. J., Meier, P. J., & Kullak-Ublick, G. A. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(05)00028-5 · Cited by 68
zu Schwabedissen, H. E. M., & Kim, R. B. (2009) · Molecular Pharmaceutics · doi:10.1021/mp9000298 · Cited by 64
Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice
Csanaky, I. L., Aleksunes, L. M., Tanaka, Y., & Klaassen, C. D. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90728.2008 · Cited by 63
FXR: a target for cholestatic syndromes?
Cai, S., & Boyer, J. L. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.3.409 · Cited by 65
“Although multiple nuclear receptors are capable of regulating MRP2 expression, it is upregulated in human and rat hepatocytes by FXR agonists, such as CDCA, GW4064 or fexaramine [40,54,55].”
BackgroundLü, H., Gonzalez, F. J., & Klaassen, C. D. (2010) · Toxicological Sciences · doi:10.1093/toxsci/kfq280 · Cited by 62
“In contrast, hepatic expression of CAR is induced in FXR-null mice (Guo et al., 2003).”
BackgroundSelf-citationEffect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers
Režen, T., Tamási, V., Lövgren‐Sandblom, A., Björkhem, I., Meyer, U., & Rozman, D. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-384 · Cited by 66
“Therefore, CAR activators are used to treat cholestasis and jaundice in humans and mice [1-4].”
BackgroundInhibition of LXRα signaling by vitamin D receptor: Possible role of VDR in bile acid synthesis
Jiang, W., Miyamoto, T., Kakizawa, T., Nishio, S., Oiwa, A., Takeda, T., Suzuki, S., & Hashizume, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.027 · Cited by 66
Master regulation of bile acid and xenobiotic metabolism via the FXR, PXR and CAR trio
Modica, S., Bellafante, E., & Moschetta, A. (2009) · Frontiers in bioscience · doi:10.2741/3563 · Cited by 63
“Among SULT enzymes, SULT2A1 and Sult2a9 are key enzymes in phase II metabolism that catalyze sulfoconjugation of xenobiotics and BAs (57,132) and are predominantly responsible for the formation of 3-alpha-sulfated BAs.”
BackgroundInfluentialMetabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR
Küblbeck, J., Niskanen, J., & Honkakoski, P. (2020) · Cells · doi:10.3390/cells9102306 · Cited by 56
Wang, Y., Yang, F., Chen, W., Huang, X., Lai, L. L., FORMAN, B. M., & Huang, W. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0527 · Cited by 62
“tatic liver injury in rats (10, 11), which suggests that a key”
BackgroundGarcia, M., Thirouard, L., Sèdes, L., Monrose, M., Holota, H., Caira, F., Volle, D. H., & Beaudoin, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113630 · Cited by 62
“This beneficial role of CAR in the protection against hepatotoxic LCA is likely attributed to the induction of phase I and II enzymes (Cyp3a4, Ugt1a1), as well as efflux transporters (Mrp2), in these cholestatic animal models [52,132,133].”
BackgroundBile Acids and GPBAR-1: Dynamic Interaction Involving Genes, Environment and Gut Microbiome
Portincasa, P., Ciaula, A. D., Garruti, G., Vacca, M., Angelis, M. D., & Wang, D. Q. ‐. (2020) · Nutrients · doi:10.3390/nu12123709 · Cited by 60
Amino Acids Important for Ligand Specificity of the Human Constitutive Androstane Receptor
Jyrkkärinne, J., Windshügel, B., Mäkinen, J., Ylisirniö, M., Peräkylä, M., Poso, A., Sippl, W., & Honkakoski, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411241200 · Cited by 61
NOX as a Therapeutic Target in Liver Disease
Matuz‐Mares, D., Vázquez‐Meza, H., & Vilchis‐Landeros, M. M. (2022) · Antioxidants · doi:10.3390/antiox11102038 · Cited by 65
Regulation of Hepatic Cytochromes P450 by Lipids and Cholesterol
Hafner, M., Režen, T., & Rozman, D. (2011) · Current Drug Metabolism · doi:10.2174/138920011795016890 · Cited by 59
Baskin-Bey, E. S., Huang, W., Ishimura, N., Isomoto, H., Bronk, S. F., Braley, K. E., Craig, R. W., Moore, D. D., & Gores, G. J. (2006) · Hepatology · doi:10.1002/hep.21236 · Cited by 55
Dempsey, J. L., Wang, D., Siginir, G., Fei, Q., Raftery, D., Gu, H., & Cui, J. Y. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy271 · Cited by 59
Vitamin D in the Context of Evolution
Carlberg, C. (2022) · Nutrients · doi:10.3390/nu14153018 · Cited by 59
The Hylemon-Björkhem pathway of bile acid 7-dehydroxylation: history, biochemistry, and microbiology
Ridlon, J. M., Daniel, S. L., & Gaskins, H. R. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100392 · Cited by 54
“Strikingly, derivatives of the hydrophobic secondary bile acid products of microbial 7-dehydroxylation, such as deoxycholic acid (DCA) and lithocholic acid (LCA), are, in general, preferred ligands for many host nuclear receptors (farnesoid X receptor (also known as NR1H4) (6–8), pregnane X receptor (or NR1I2) (9), vi…”
BackgroundEvidence for triclosan-induced activation of human and rodent xenobiotic nuclear receptors
Friedman, K. P., Thompson, J. T., Simmons, S. O., Heuvel, J. P. V., & Crofton, K. M. (2013) · Toxicology in Vitro · doi:10.1016/j.tiv.2013.07.008 · Cited by 61
Sberna, A.-L., Assem, M., Gautier, T., Grober, J., Guiu, B., Jeannin, A., de Barros, J.-P. P., Athias, A., Lagrost, L., & Masson, D. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.10.029 · Cited by 51
“In these models, pharmacological CAR activation reduced bile acid toxicity [7,8,11] while, in contrast, CAR deficiency resulted in an exacerbation of liver damage [7,9,12].”
InfluentialSulfotransferase genes: Regulation by nuclear receptors in response to xeno/endo-biotics
Kodama, S., & Negishi, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2013.835630 · Cited by 53
“CAR, overexpressed in FXR-KO mice and FXR/PXR-double KO mice, compensates the functions of FXR and PXR (Guo et al., 2003).”
BackgroundSelf-citationLi, G., Kong, B., Zhu, Y., Zhan, L., Williams, J. A. R., Tawfik, O. W., Kassel, K. M., Luyendyk, J. P., Wang, L., & Guo, G. L. (2013) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2013.06.016 · Cited by 52
“SHP is a well-known FXR target gene (Guo et al., 2003), and over-expression of SHP inhibits HCC foci formation and arrests HCC tumor growth in xenografted nude mice models (He et al., 2008; Zhang et al., 2008).”
Self-citationRoma, M. G., Crocenzi, F. A., & Pozzi, E. J. S. (2008) · Clinical Science · doi:10.1042/cs20070227 · Cited by 53
Houten, S. M., & Auwerx, J. H. (2004) · Annals of Medicine · doi:10.1080/07853890410018790 · Cited by 54
Anapolsky, A., Teng, S., Dixit, S. G., & Piquette‐Miller, M. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.006197 · Cited by 49
“Since that time, various studies have shown that induction of CYP3A by a variety of xenobiotics is primarily mediated by PXR (Bertilsson et al., 1998; Lehman et al., 1998; Guo et al., 2003).”
BackgroundCAR2 Displays Unique Ligand Binding and RXRα Heterodimerization Characteristics
Auerbach, S. S., DeKeyser, J. G., Stoner, M. A., & Omiecinski, C. J. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012641 · Cited by 48
“, 2004a), bile acids (Guo et al., 2003; Saini et al., 2004; Zhang et al., 2004), and thyroid hormone (Maglich et al.”
BackgroundFarnesoid X Receptor Antagonizes JNK Signaling Pathway in Liver Carcinogenesis by Activating SOD3
Wang, Y., Chen, W., Li, C., Guo, C., Li, Y., Qi, H. M., Shen, H., Kong, J., Long, X., Yuan, F., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1225 · Cited by 47
“Moreover, FXR activation alleviates the hepatotoxicity of hepatotoxins (7–9), protects against cholestatic liver injury in rats (10, 11), suppresses serum deprivation-in-”
BackgroundMarino, S. D., Ummarino, R., D’Auria, M. V., Chini, M. G., Bifulco, G., D’Amore, C., Renga, B., Mencarelli, A., Petek, S., Fiorucci, S., et al. (2012) · Steroids · doi:10.1016/j.steroids.2012.01.006 · Cited by 48
Wagner, M., & Trauner, M. (2005) · Annals of Hepatology · doi:10.1016/s1665-2681(19)32071-x · Cited by 53
Ding, L., Pang, S., Sun, Y., Tian, Y., Li, Y., & Dang, N. (2014) · International Journal of Endocrinology · doi:10.1155/2014/751859 · Cited by 54
“However, abundant evidence indicates that FXR is of vital importance, as deletion of FXR inmice causes marked changes in bile acid homeostasis [26, 27].”
BackgroundGenomic signaling of vitamin D
Carlberg, C. (2023) · Steroids · doi:10.1016/j.steroids.2023.109271 · Cited by 48
Cho, J., Matsubara, T., Kang, D. W., Ahn, S., Krausz, K. W., Idle, J. R., Luecke, H. F., & Gonzalez, F. J. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m002923 · Cited by 45
Self-citationDong, B., Qatanani, M., & Moore, D. D. (2009) · Hepatology · doi:10.1002/hep.23025 · Cited by 46
Masson, D., Qatanani, M., Sberna, A.-L., Xiao, R., de Barros, J.-P. P., Grober, J., Deckert, V., Athias, A., Gambert, P., Lagrost, L., et al. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m700374-jlr200 · Cited by 45
Hrycay, E. G., Forrest, D., Liu, L., Wang, R., Tai, J. K., Deo, A. K., Ling, V. W. T., & Bandiera, S. M. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1933-y · Cited by 44
“Increased hepatic Cyp3a/Cyp3a11 gene (or protein) expression was previously noted in Pxr [40, 58–60], Fxr [58, 61], Cyp27a1 [62] and liver X receptor”
BackgroundROLE OF THE NUCLEAR RECEPTOR PREGNANE X RECEPTOR IN ACETAMINOPHEN HEPATOTOXICITY
Wolf, K., Wood, S. G., Hunt, J. A., Walton-Strong, B. W., Yasuda, K., Lan, L.-B., Duan, S. X., Hao, Q., Wrighton, S. A., Jeffery, E. H., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005256 · Cited by 42
“Consistent with findings in the liver (Guo et al., 2003), mdr1a mRNA (Fig.”
BackgroundResultInfluentialWhitfield, G. K., Jurutka, P. W., Haussler, C. A., Hsieh, J., Barthel, T. K., Jacobs, E. T., Dominguez, C. E., Thatcher, M. L., & Haussler, M. R. (2005) · Elsevier eBooks · doi:10.1016/b978-012252687-9/50016-4 · Cited by 48
Maternal bile acid transporter deficiency promotes neonatal demise
Zhang, Y., Li, F., Wang, Y., Pitre, A., Fang, Z., Frank, M. W., Calabrese, C. R., Krausz, K. W., Neale, G. A. M., Frase, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9186 · Cited by 41
Self-citationNi, X., Gao, Y., Wu, Z., Ma, L., Chen, C., Wang, L., Lin, Y., Hui, L., & Pan, G. (2016) · Scientific Reports · doi:10.1038/srep38694 · Cited by 42
Activation of Constitutive Androstane Receptor Prevents Cholesterol Gallstone Formation
Cheng, S., Zou, M., Liu, Q., Kuang, J., Shen, J., Pu, S., Chen, L., Li, H., Wu, T., Li, R., et al. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.12.013 · Cited by 41
“Previous studies have shown that CAR played an important role in xenobiotic molecular elimination and also controlled the metabolism of endogenous compounds such as BAs and triglycerides.(26,33,34) Despite the activation of Cyp7a1, our TCPOBOP-treated mice showed a constant biliary level of BAs, which was due to the u…”
BackgroundTien, E. S., Matsui, K., Moore, R., & Negishi, M. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.112706 · Cited by 43
“In addition to P450s, CAR is also known to regulate organic anion transporters, such as organic anion transporting polypeptide 2 and multidrug resistance gene 3 (MDR3), which aid in the removal of bile salts, bilirubin, and hormones, including thyroid hormone, from the blood (Friesema et al., 1999; Guo et al., 2003; S…”
BackgroundSelf-citationSberna, A.-L., Assem, M., Xiao, R., Ayers, S., Gautier, T., Guiu, B., Deckert, V., Chevriaux, A., Grober, J., Guern, N. L., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.222497 · Cited by 41
Pradhan‐Sundd, T., Kosar, K., Saggi, H., Zhang, R., Vats, R., Cornuet, P. K., Green, S., Singh, S., Zeng, G., Sundd, P., et al. (2019) · Hepatology · doi:10.1002/hep.30927 · Cited by 40
Jia, X., Naito, H., Yetti, H., Tamada, H., Kitamori, K., Hayashi, Y., Wang, D., Yanagiba, Y., Wang, J., Ikeda, K., et al. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2747-1 · Cited by 40
“On one hand, the downward shift of nuclear FXR expression in HFC-fed rats may correlate with the suppressed transcription of BSEP; on the other hand, downregulated PXR and CAR may result in reduced UGT activity and SULT2A1 protein.”
BackgroundInfluentialSakai, H., Iwata, H., Kim, E., Tsydenova, O. V., Miyazaki, N., Петров, Е. А., Batoev, V. B., & Tanabe, S. (2006) · Toxicological Sciences · doi:10.1093/toxsci/kfl088 · Cited by 40
“Before starting the reporter gene assay, we initially confirmed mRNA expression of endogenous CAR, PXR, VDR, and FXR in MCF-7 using RT-PCR, because these receptors are functionally similar and potentially activate NR1 site (Guo et al., 2003; Handschin and Meyer, 2005).”
MethodSmall-molecule modulators of the constitutive androstane receptor
Cherian, M. T., Chai, S. C., & Chen, T. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1043887 · Cited by 40
“Androgens, estradiol, and their metabolites undergo sulfation by SULTs and glucuronidation by UGTs as part of their metabolic breakdown and excretion, and many of these Phase II enzymes are target genes of CAR [71,72].”
BackgroundJyrkkärinne, J., Windshügel, B., Rönkkö, T., Tervo, A. J., Küblbeck, J., Lahtela-Kakkonen, M. K., Sippl, W., Poso, A., & Honkakoski, P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800731b · Cited by 39
Linkage disequilibrium blocks, haplotype structure, and htSNPs of human CYP7A1 gene
Nakamoto, K., Wang, S., JENISON, R. D., Guo, G. L., Klaassen, C. D., Wan, Y. Y., & Zhong, X.-B. (2006) · BMC Genetics · doi:10.1186/1471-2156-7-29 · Cited by 38
“Within this network, nuclear receptors of farnesoid X receptor (FXR), liver X receptor (LXR), retinoid X receptor (RXR), small heterodimer partner (SHP), and liver receptor homologue 1 (LRH1) are involved in a positive-versus-negative regulation.”
BackgroundSelf-citationSome Experimental Models of Liver Damage
Muriel, P. (2007) · Wiley eBooks · doi:10.1002/9780470516751.ch6 · Cited by 43
Current In Vitro High Throughput Screening Approaches to Assess Nuclear Receptor Activation
Raucy, J. L., & Lasker, J. M. (2010) · Current Drug Metabolism · doi:10.2174/138920010794328896 · Cited by 37
Genomic and non-genomic interactions of PPARα with xenobiotic-metabolizing enzymes
Barbier, O., Fontaine, C., Fruchart, J., & Staels, B. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.07.007 · Cited by 37
Miyata, M., Tozawa, A., Otsuka, H., Nakamura, T., Nagata, K., Gonzalez, F. J., & Yamazoe, Y. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.076158 · Cited by 39
“Recently, it was reported that constitutive androstane receptor is also involved in protection against cholic acid-induced toxicity by using PXR-FXR double null mice (Guo et al., 2003).”
BackgroundSelf-citationZhang, C., Shi, Z., Lei, H., Wu, F., Chen, C., Cao, Z., Song, Y., Zhang, C., Zhou, J., Lu, Y., et al. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c00952 · Cited by 36
Epigenomic regulation of bile acid metabolism: Emerging role of transcriptional cofactors
Smith, Z., Ryerson, D., & Kemper, J. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.008 · Cited by 36
“…a FXR and PXR double knockout mouse model, Guo et al. has demonstrated that FXR, PXR, and CAR function as transcriptional regulators of hepatic genes, including bile acid metabolizing genes, and, therefore, protect the liver against bile acid toxicity in a complementary manner (Guo et al 2003).”
BackgroundMasson, D., Lagrost, L., Athias, A., Gambert, P., Brimer, C., Lan, L.-B., Schuetz, J. D., Schuetz, E. G., & Assem, M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000183674.88817.fb · Cited by 37
Keely, S. J., Urso, A., Ilyaskin, A. V., Korbmacher, C., Bunnett, N. W., Poole, D. P., & Carbone, S. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00125.2021 · Cited by 41
Regulation of human liver δ-aminolevulinic acid synthase by bile acids
Peyer, A., Jung, D., Beer, M., Gnerre, C., Keogh, A., Stroka, D., Zavolan, M., & Meyer, U.-A. (2007) · Hepatology · doi:10.1002/hep.21879 · Cited by 35
Polymorphisms of human nuclear receptors that control expression of drug-metabolizing enzymes
Okey, A. B., Boutros, P. C., & Harper, P. A. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200506000-00001 · Cited by 35
de Haan, L. R., van der Lely, S. J., Warps, A. K., Hofsink, Q., Olthof, P. B., de Keijzer, M. J., Lionarons, D. A., Dias, L. M., Bruinsma, B. G., Uygun, K., et al. (2018) · Journal of Clinical and Translational Research · doi:10.18053/jctres.04.201801.001 · Cited by 35
Marín, J. J. G., Macías, R. I. R., Briz, Ó., Perez, M. J., Blazquez, A. G., Arrese, M. A., & Serrano, M. A. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01680.x · Cited by 37
“The constitutive androstane receptor (CAR; NR1I3) can be activated by bilirubin (170), although it is also sensitive to certain species of BAs (171).”
BackgroundOswald, S., Westrup, S., Grube, M., Kroemer, H. K., Weitschies, W., & Siegmund, W. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104018 · Cited by 37
“…animals may result from induction of the nuclear farnesoid X receptor, PXR, and constitutive androstane receptor by bile acids that are elevated in Mrp2-deficient animals and known inducers of the mentioned nuclear receptors (Takikawa et al., 1991; Xie et al., 2001; Guo et al., 2003).”
BackgroundMechanisms of STAT3 activation in the liver of FXR knockout mice
Li, G., Zhu, Y., Tawfik, O. W., Kong, B., Williams, J. A. R., Zhan, L., Kassel, K. M., Luyendyk, J. P., Wang, L., & Guo, G. L. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00155.2013 · Cited by 38
Self-citationBile acid activated receptors are targets for regulation of integrity of gastrointestinal mucosa
Distrutti, E., Santucci, L., Cipriani, S., Renga, B., Schiaroli, E., Ricci, P., Donini, A., & Fiorucci, S. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-015-1041-8 · Cited by 33
“Secretion of phospholipids by hepatocytes in the bile requires the activity of a family of transporters, including multidrug resistance protein 2 and multidrug resistance protein 3 [53–56].”
BackgroundParaiso, I. L., Tran, T. Q., Magaña, A. A., Kundu, P., Choi, J., Maier, C. S., Bobe, G., Raber, J., Kioussi, C., & Stevens, J. F. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.643857 · Cited by 35
“FXR, PXR and CAR have complementary roles in the protection against BA toxicity (Guo et al., 2003).”
BackgroundXing, X., Burgermeister, E., Geisler, F., Einwächter, H., Fan, L., Hiber, M., Rauser, S., Walch, A. K., Röcken, C., Ebeling, M., et al. (2008) · Hepatology · doi:10.1002/hep.22712 · Cited by 34
Lee, M. D., Ayanoĝlu, E., & Gong, L. (2006) · Xenobiotica · doi:10.1080/00498250600861785 · Cited by 34
“Several studies have demonstrated that PXR and CAR function coordinately to prevent and ameliorate bile acid-induced hepatotoxicity (Guo et al. 2003, Zhang et al. 2004, Stedman et al. 2005).”
BackgroundBailey, I., Gibson, G. G., Plant, K. E., Graham, M., & Plant, N. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016703 · Cited by 35
“This poor response indicates that while CAR, LXR and VDR are all implicated in small areas of bile acid biosynthesis, FXR and PXR are the dominant receptors responsible for control in this system [40].”
BackgroundAnticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis
Razori, M. V., Maidagán, P. M., Ciriaci, N., Andermatten, R. B., Barosso, I. R., Martín, P. L., Basiglio, C. L., Pozzi, E. J. S., Ruiz, M. L., & Roma, M. G. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.009 · Cited by 34
Clinical Relevance of the Constitutive Androstane Receptor
Stern, S., Kurian, R., & Wang, H. (2022) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000483 · Cited by 33
“inflammation, and oxidative stress (Guo et al., 2003; Zhang et al., 2004; Stedman et al., 2005; Gabbia et al., 2018).”
BackgroundStahl, S. H., Davies, M. R., Cook, D. I., & Graham, M. J. (2008) · Xenobiotica · doi:10.1080/00498250802105593 · Cited by 35
“However, FXR expression itself can be subject to change in experimental models of cholestasis such as CA feeding or in response to endotoxin challenge where reduced expression has been observed (Fang et al. 2004; Guo et al. 2003; Kim et al. 2003).”
BackgroundInfluentialEnriquez, A. B., ten-Caten, F., Ghneim, K., Sékaly, R., & Sharma, A. (2023) · Annual Review of Virology · doi:10.1146/annurev-virology-040323-082822 · Cited by 29
Hepatobiliary ABC transporters: physiology, regulation and implications for disease
Jonker, J. W. (2009) · Frontiers in bioscience · doi:10.2741/3576 · Cited by 41
“concentrations of dietary CA cause a marked increase in serum, liver and urine bile acid concentrations, and severe hepatotoxicity in FXR knockout mice, associated with the loss of expression of Abcb11, and reduced biliary elimination of bile acids (117, 125, 143).”
BackgroundAuman, J. T., Chou, J.-H., Gerrish, K., Huang, Q., Jayadev, S., Blanchard, K. T., & Paules, R. S. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9396 · Cited by 27
“NM_052980), which have been shown to maintain cholesterol and lipid homeostasis (Guo et al. 2003; Lambert et al. 2003), are down-regulated in high-dose livers only (pattern nos.”
Opposing regulation of cytochrome P450 expression by CAR and PXR in hypothyroid mice
Park, Y. J., Lee, E. K., Lee, Y., Park, D. J., Jang, H. C., & Moore, D. D. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.03.017 · Cited by 27
“While PXR acts primarily as a direct xenobiotic receptor, CAR can be activated indirectly by diverse metabolic stresses (Qatanani et al., 2005), including type 1 diabetes (Dong et al., 2009), fasting (Maglich et al., 2004) and cholestasis (Guo et al., 2003; Zhang et al., 2004).”
BackgroundIntestinal Detoxification Limits the Activation of Hepatic Pregnane X Receptor by Lithocholic Acid
Owen, B. M., Milona, A., van Mil, S. W. C., Clements, P., Holder, J. C., Boudjelal, M., Cairns, W. J., Parker, M. G., White, R., & Williamson, C. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.109.029306 · Cited by 28
“, 2001) and Mrp2 (Guo et al., 2003).”
BackgroundClinical Hepatotoxicity. Regulation and Treatment with Inducers of Transport and Cofactors
Marschall, H., Wagner, M., Zollner, G., & Trauner, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060133c · Cited by 30
Lickteig, A. J., Csanaky, I. L., Pratt-Hyatt, M., & Klaassen, C. D. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw054 · Cited by 26
“It has been shown in BA-feeding and bile duct-ligation models of cholestasis that CAR activators, such as TCPOBOP and PB, activate pathways of BA detoxification and protect against BAinduced liver injury (Guo et al., 2003; Wagner et al., 2005; Beilke et al., 2009; Sberna et al., 2011).”
BackgroundRzeczycki, P., Pęciak, O., Plust, M., & Droździk, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411897 · Cited by 30
García, A., Zeng, Y., Muthupalani, S., Ge, Z., Potter, A. F., Mobley, M. W., Boussahmain, C., Feng, Y., Wishnok, J. S., & Fox, J. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1975 · Cited by 28
“complementary manner and nuclear receptors can be modulated by synthetic drugs and natural products (48, 49).”
Haussler, M. R., Whitfield, G. K., Haussler, C. A., Hsieh, J., & Jurutka, P. W. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-381978-9.10008-3 · Cited by 29
Metadata
- Authors
- Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J.
- Affiliations
- National Institutes of Health (US)
- Inserm (FR)
- National Cancer Institute (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Gonzalez, Frank J.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-11
- Volume
- 278
- Issue
- 46
- Pages
- 45062-45071
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2168485100
- Cited by
- 312
- References
- 37
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 7 · 2023: 10 · 2022: 7 · 2021: 8 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 10 · 2016: 6 · 2015: 6 · 2014: 9 · 2013: 20 · 2012: 13
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6175 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- farnesoid X receptor, pregnane X receptor, constitutive androstane receptor, bile acid toxicity, cholic acid, bile acid homeostasis, cholesterol homeostasis, lipid homeostasis, cholestasis, bilirubin metabolism, phenobarbital, TCPOBOP, CYP2B, CYP3A, MRP2, MRP3, UGT1A, alpha-glutathione S-transferase
- MeSH terms
- Pregnane X Receptor, Constitutive Androstane Receptor, Receptor, Farnesoid X-Activated, Animals, Animal Feed, Aryl Hydrocarbon Hydroxylases, Bile Acids and Salts, Bilirubin, Biological Transport, Body Weight, Cell Nucleus, Cholesterol, Cloning, Molecular, Crosses, Genetic, DNA-Binding Proteins, Glutathione Transferase, Liver, Mice, Transgenic, Oxidoreductases, N-Demethylating, Phenobarbital, Phospholipids, Pyridines, Receptors, Steroid, Ribosomal Proteins, Time Factors, Transcription Factors, Blotting, Northern, Up-Regulation, Gene Deletion, Receptors, Cytoplasmic and Nuclear, Mitochondrial Proteins, Saccharomyces cerevisiae Proteins, Lipid Metabolism, Mice, Cytochrome P-450 CYP3A
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.